Weili Duan

1.4k total citations
24 papers, 931 citations indexed

About

Weili Duan is a scholar working on Molecular Biology, Cancer Research and Epidemiology. According to data from OpenAlex, Weili Duan has authored 24 papers receiving a total of 931 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 16 papers in Cancer Research and 5 papers in Epidemiology. Recurrent topics in Weili Duan's work include Cancer-related molecular mechanisms research (15 papers), Circular RNAs in diseases (10 papers) and MicroRNA in disease regulation (7 papers). Weili Duan is often cited by papers focused on Cancer-related molecular mechanisms research (15 papers), Circular RNAs in diseases (10 papers) and MicroRNA in disease regulation (7 papers). Weili Duan collaborates with scholars based in China, Canada and Belgium. Weili Duan's co-authors include Chuanxin Wang, Lutao Du, Xiumei Jiang, Lili Wang, Yongmei Yang, Yujiao Xie, Suzhen Yan, Keqiang Yan, Yunshan Wang and Yinghui Zhao and has published in prestigious journals such as PLoS ONE, Cell Death and Differentiation and Neuropharmacology.

In The Last Decade

Weili Duan

23 papers receiving 922 citations

Peers

Countries citing papers authored by Weili Duan

Since Specialization

Citations

This map shows the geographic impact of Weili Duan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weili Duan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weili Duan more than expected).

Fields of papers citing papers by Weili Duan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Weili Duan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weili Duan. The network helps show where Weili Duan may publish in the future.

Co-authorship network of co-authors of Weili Duan

This figure shows the co-authorship network connecting the top 25 collaborators of Weili Duan. A scholar is included among the top collaborators of Weili Duan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Weili Duan. Weili Duan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Ubiquitin-specific protease 48 drives malignant progression of colorectal cancer by suppressing autophagy through stabilizing sequestosome 1 2025 ·Cell Death and Differentiation ·(unknown), Aijing Liu, Weili Duan, Yanru Li, Xue Kong, (unknown), Dun Niu, Shaojun Liu, Peng Zhang, (unknown), Peilong Li, Lutao Du	0
2	A novel long non-coding RNA AC073352.1 promotes metastasis and angiogenesis via interacting with YBX1 in breast cancer 2021 ·Cell Death and Disease ·Xue Kong, Juan Li, Yanru Li, Weili Duan, Qiuchen Qi, Tiantian Wang, Qifeng Yang, Lutao Du, Haiting Mao, Chuanxin Wang	35
3	A nomogram combining long non-coding RNA expression profiles and clinical factors predicts survival in patients with bladder cancer 2020 ·Aging ·Yifan Wang, Lutao Du, Xuemei Yang, Juan Li, Peilong Li, Yinghui Zhao, Weili Duan, Ying‐Jie Chen, Yunshan Wang, Haiting Mao, Chuanxin Wang	33
4	<p>Evaluation of Serum Exosomal lncRNAs as Diagnostic and Prognostic Biomarkers for Esophageal Squamous Cell Carcinoma</p> 2020 ·Cancer Management and Research ·Suzhen Yan, Lutao Du, Xiumei Jiang, Weili Duan, Juan Li, Yujiao Xie, Yao Zhan, Shujun Zhang, Lili Wang, Shuhai Li, Chuanxin Wang	31
5	Individualized Prediction of Survival by a 10-Long Non-coding RNA-Based Prognostic Model for Patients With Breast Cancer 2020 ·Frontiers in Oncology ·Xuemei Yang, Juan Li, Yifan Wang, Peilong Li, Yinghui Zhao, Weili Duan, Abakundana Nsenga Ariston Gabriel, Ying‐Jie Chen, Haiting Mao, Yunshan Wang, Lutao Du, Chuanxin Wang	5
6	Long noncoding RNA LINC02418 regulates MELK expression by acting as a ceRNA and may serve as a diagnostic marker for colorectal cancer 2019 ·Cell Death and Disease ·Yinghui Zhao, Tiantian Du, Lutao Du, Peilong Li, Juan Li, Weili Duan, Yunshan Wang, Chuanxin Wang	73
7	Circulating long noncoding RNA act as potential novel biomarkers for diagnosis and prognosis of non‐small cell lung cancer 2018 ·Molecular Oncology ·Yujiao Xie, Yi Zhang, Lutao Du, Xiumei Jiang, Suzhen Yan, Weili Duan, Juan Li, Yao Zhan, Lili Wang, Shujun Zhang, Shuhai Li, Lishui Wang, Shuo Xu, Chuanxin Wang	128
8	Cell‐free lncRNA expression signatures in urine serve as novel non‐invasive biomarkers for diagnosis and recurrence prediction of bladder cancer 2018 ·Journal of Cellular and Molecular Medicine ·Lutao Du, Weili Duan, Xiumei Jiang, Li Zhao, Juan Li, Rui Wang, Suzhen Yan, Yujiao Xie, Keqiang Yan, Qingliang Wang, Lili Wang, Yongmei Yang, Chuanxin Wang	51
9	Identification of circulating microRNA signatures as potential noninvasive biomarkers for prediction and prognosis of lymph node metastasis in gastric cancer 2017 ·Oncotarget ·Xiumei Jiang, Wenfei Wang, Yongmei Yang, Lutao Du, Xiaoyun Yang, Lili Wang, Guixi Zheng, Weili Duan, Rui Wang, Xin Zhang, Lishui Wang, Xiaoyang Chen, Chuanxin Wang	25
10	Identification of long noncoding RNAs as potential novel diagnosis and prognosis biomarkers in colorectal cancer 2016 ·Journal of Cancer Research and Clinical Oncology ·Rui Wang, Lutao Du, Xiaoyun Yang, Xiumei Jiang, Weili Duan, Suzhen Yan, Yujiao Xie, Yuntao Zhu, Qingliang Wang, Lili Wang, Yongmei Yang, Chuanxin Wang	61
11	Identification of a serum circulating lncRNA panel for the diagnosis and recurrence prediction of bladder cancer 2016 ·Oncotarget ·Weili Duan, Lutao Du, Xiumei Jiang, Rui Wang, Suzhen Yan, Yujiao Xie, Keqiang Yan, Qingliang Wang, Lili Wang, Xin Zhang, Hongwei Pan, Yongmei Yang, Chuanxin Wang	104
12	Serum microRNA expression signatures as novel noninvasive biomarkers for prediction and prognosis of muscle-invasive bladder cancer 2016 ·Oncotarget ·Xiumei Jiang, Lutao Du, Weili Duan, Rui Wang, Keqiang Yan, Lili Wang, Juan Li, Guixi Zheng, Xin Zhang, Yongmei Yang, Chuanxin Wang	48
13	Serum miR-210 Contributes to Tumor Detection, Stage Prediction and Dynamic Surveillance in Patients with Bladder Cancer 2015 ·PLoS ONE ·Yongmei Yang, Ailin Qu, (unknown), Rui Wang, Yingjie Liu, Gang Li, Weili Duan, Fang Qian, Xiumei Jiang, Lili Wang, Guixi Zheng, Lutao Du, Xin Zhang, Chuanxin Wang	37
14	The cPLA2α inhibitor efipladib decreases nociceptive responses without affecting PGE2 levels in the cerebral spinal fluid 2010 ·Neuropharmacology ·Cheryl Nickerson‐Nutter, Debra G. Goodwin, Marina W. H. Shen, (unknown), Weili Duan, Tarek A. Samad, John C. McKew, Katherine L. Lee, Margaret M. Zaleska, Névéna Mollova, James D. Clark	5
15	A human osteosarcoma cell line expressing herpes simplex type-1 thymidine kinase: studies with radiolabeled (E)-5-(2-iodovinyl)-2′-fluoro-2′-deoxyuridine 2005 ·Nuclear Medicine and Biology ·(unknown), Weili Duan, Edward E. Knaus, Alexander McEwan, Leonard I. Wiebe	1
16	Cytotoxicity and cellular uptake of pyrimidine nucleosides for imaging herpes simplex type-1 thymidine kinase (HSV-1 TK) expression in mammalian cells 2004 ·Nuclear Medicine and Biology ·(unknown), Weili Duan, Lihua Xu, Aihua Zhou, (unknown), Edward E. Knaus, Alexander McEwan, Leonard I. Wiebe	18
17	ChemInform Abstract: Synthesis of 1‐[(2‐Hydroxyethoxy)methyl]‐ and 1‐[(1,3‐Dihydroxy‐2‐propoxy)methyl]‐ Derivatives of 5‐Substituted‐2,4‐difluorobenzene: Unnatural Acyclo Thymidine Mimics for Evaluation as Anticancer and Antiviral Agents. 2002 ·ChemInform ·Zhixian Wang, Weili Duan, Leonard I. Wiebe, Erik De Clercq, Jan Balzarini, Edward E. Knaus	1
18	SYNTHESIS OF 1-(2-DEOXY-β-D-RIBOFURANOSYL)-2,4-DIFLUORO-5-SUBSTITUTED-BENZENES^: “THYMINE REPLACEMENT” ANALOGS OF THYMIDINE FOR EVALUATION AS ANTICANCER AND ANTIVIRAL AGENTS 2001 ·Nucleosides Nucleotides & Nucleic Acids* ·Zhixian Wang, Weili Duan, Leonard I. Wiebe, Jan Balzarini, Erik De Clercq, Edward E. Knaus	6
19	SYNTHESIS OF 1-(2-DEOXY-β-D- RIBOFURANOSYL)-2,4-DIFLUORO-5-SUBSTITUTED-BENZENE THYMIDINE MIMICS,^SOME RELATED α-ANOMERS, AND THEIR EVALUATION AS ANTIVIRAL AND ANTICANCER AGENTS 2001 ·Nucleosides Nucleotides & Nucleic Acids* ·Zhixian Wang, Weili Duan, Leonard I. Wiebe, Jan Balzarini, Erik De Clercq, Edward E. Knaus	26
20	Syntheses of 1-[(2-Hydroxyethoxy)methyl]- and 1-[(1,3-Dihydroxy-2-Propoxy)methyl]- Derivatives of 5-Substituted-2,4-difluorobenzene: Unnatural Acyclo Thymidine Mimics for Evaluation as Anticancer and Antiviral Agents 2000 ·Nucleosides Nucleotides & Nucleic Acids ·Zhixian Wang, Weili Duan, Leonard I. Wiebe, Erik De Clercq, Jan Balzarini, Edward E. Knaus	4

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact